BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8258826)

  • 1. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
    Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
    J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.
    Thomas AP; Allott CP; Gibson KH; Major JS; Masek BB; Oldham AA; Ratcliffe AH; Roberts DA; Russell ST; Thomason DA
    J Med Chem; 1992 Mar; 35(5):877-85. PubMed ID: 1548677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
    Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
    Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
    Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil.
    Naka T; Kubo K; Inada Y; Nishikawa K
    Drug Des Discov; 1999 Aug; 16(2):95-108. PubMed ID: 10533806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.
    Bradbury RH; Allott CP; Dennis M; Fisher E; Major JS; Masek BB; Oldham AA; Pearce RJ; Rankine N; Revill JM
    J Med Chem; 1992 Oct; 35(22):4027-38. PubMed ID: 1433210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil.
    Naka T; Kubo K
    Curr Pharm Des; 1999 Jun; 5(6):453-72. PubMed ID: 10390609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
    Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
    J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
    Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
    Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
    Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
    Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
    J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.
    Bovy PR; Reitz DB; Collins JT; Chamberlain TS; Olins GM; Corpus VM; McMahon EG; Palomo MA; Koepke JP; Smits GJ
    J Med Chem; 1993 Jan; 36(1):101-10. PubMed ID: 8421274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.